Addiction

ABSTRACT Background: The psychoactive indole alkaloid ibogaine has been associated with encouraging treatment outcomes for opioid dependence. The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability...

Abstract Background: Ibogaine is an agent that has been evaluated as an unapproved anti-addictive agent for the management of drug dependence. Sudden cardiac death has been described to occur secondary to its use. We describe the clinical...

ABSTRACT Background: Ibogaine is a monoterpene indole alkaloid used in medical and nonmedical settings for the treatment of opioid use disorder. Its mechanism of action is apparently novel. There are no published prospective studies of drug...

This study aimed to report on the prevalence of alcohol, tobacco, illicit drugs and medical drugs used outside of prescription among seniors enrolled in the food pension program Hai-DF in Mexico City.

This fact sheet can be used as a guide for people seeking mental health treatment. It offers three steps to carry out before using a treatment center, as well as the five signs of a treatment center of quality, which includes reviewing the...

Análisis del fenómeno del consumo de drogas sintéticas a partir de la información surgida de la investigación y compilación de datos científicos.

Los resultados de un estudio en el que han participado 1.276 personas de 80 países diferentes, todas ellas residentes en España o en países hispanohablantes, apuntan a que más de la mitad de los menores de 18 años experimentan problemas...

A infographic resource from the National Institute on Drug Abuse (NIDA) exploring the drug related death statistics relating to fentanyl and other synthetic opioids reported in the United States. With nearly 50% of opioid related deaths...